ACO Name and Location

PQN – Central Texas, LLC
950 N Glebe Rd Suite 700
Arlington, VA 22203

ACO Primary Contact

Michael Richmond
Phone: 203-994-0559
Email: mrichmond@priviahealth.com

Organizational Information

ACO Participants:

ACO Participants ACO Participant in Joint Venture
Texas Health Care, P.L.L.C. (Privia Medical Group NTX) N
Stephenville Medical and Surgical Clinic PA N

ACO Governing Body:

Member First Name Member Last Name Member Title/Position Member’s Voting Power –Expressed as a percentage or number Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Larry Tatum, M.D. Director 1 ACO Participant Representative Texas Health Care P.L.L.C./Privia Medical Group NTX
David Stroman, M.D. Director 1 ACO Participant Representative Texas Health Care P.L.L.C./Privia Medical Group NTX
Travis Crudup, M.D. Director 1 ACO Participant Representative Texas Health Care P.L.L.C./Privia Medical Group NTX
Jason Ledbetter, M.D. Director 1 ACO Participant Representative Texas Health Care P.L.L.C./Privia Medical Group NTX
Lynne Tilkin, D.O. Director 1 ACO Participant Representative Texas Health Care P.L.L.C./Privia Medical Group NTX
Michelle Torres, M.D. Director 1 ACO Participant Representative Texas Health Care P.L.L.C./Privia Medical Group NTX
James Parker, M.D. Director 1 ACO Participant Representative Texas Health Care P.L.L.C./Privia Medical Group NTX
William Maxwell, M.D. Director 1 ACO Participant Representative Texas Health Care P.L.L.C./Privia Medical Group NTX
James Harvey, M.D. Director 1 ACO Participant Representative Texas Health Care P.L.L.C./Privia Medical Group NTX
Shawn Morris Director 1 Chief Executive Officer, Privia Health N/A
Parth Mehrotra Director 1 Chief Executive Officer, Privia Health N/A
Don Dearmore Director 1 Medicare Beneficiary Representative N/A

Key ACO Clinical and Administrative Leadership:

  • ACO Executive: Larry Tatum, M.D.
  • Medical Director: Raymond Blair, M.D.
  • Compliance Officer: Dana Fields
  • Quality Assurance/Improvement Officer: Lynne Tilkin, D.O.

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name & Position
 Clinical Performance  James Parker, M.D. – Chair
 Finance Committee  Michelle Torres, M.D. – Chair
 Infrastructure Committee  Chris Voigt – Chair
 Membership Committee Jason Ledbetter, M.D. – Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement


Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2021: $2,740,199.17
    • Performance Year 2020: $0
    • Performance Year 2019: $1,407,570.88
    • Performance Year 2018: $2,232,723

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2021
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribution to ACO participants: 45%
    • Performance Year 2020
      • Proportion invested in infrastructure: n/a
      • Proportion invested in redesigned care processes/resources: n/a
      • Proportion of distribution to ACO participants: n/a
    • Performance Year 2019
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribution to ACO participants: 45%
    • Performance Year 2018
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribution to ACO participants: 45%

Quality Performance Results

2021 Quality Performance Results:

Measure # Measure Name Rate ACO
Mean
Measure # 001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control2 7.89 12.46
Measure # 134 Preventative Care and Screening: Screening for Depression and Follow-up Plan 66.67 74.38
Measure # 236 Controlling High Blood Pressure 83.52 74.87
Measure #318 Falls: Screening for Future Fall Risk 88.67 87.03
Measure #110 Preventative Care and Screening: Influenza Immunization 76.27 80.52
Measure #226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention 80.49 80.97
Measure #113 Colorectal Cancer Screening 79.58 73.63
Measure #112 Breast Cancer Screening 74.62 75.11
Measure #438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 77.65 84.24
Measure #479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups2 0.1522 0.154
Measure #MCC1 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)2 28.04 33.99
       
Measure # Measure Name Rate ACO
Mean
CAHPS-1 Getting Timely Care, Appointments, and Information 91.76 84.67
CAHPS-2 How Well Providers Communicate 94.96 93.56
CAHPS-3 Patient’s Rating of Provider 94.3 92.19
CAHPS-4 Access to Specialists 79.96 78.8
CAHPS-5 Health Promotion and Education 60.7 61.61
CAHPS-6 Shared Decision Making 62.8 60.89
CAHPS-7 Health Status and Functional Status 73.31 71.78
CAHPS-8 Care Coordination 88.21 85.66
CAHPS-9 Courteous and Helpful Office Staff 93.51 91.88
CAHPS-11 Stewardship of Patient Resources 30.1 24.71

Please note, the Quality ID #: 370 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov